Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 April 2022 | Story Anthony Mthembu | Photo Supplied
Siphilangenkosi Dlamini.

“The reason I write is because I know that there will be a time when people such as my grandmother and her peers will not be around to tell us stories by word of mouth, hence we need to preserve the stories they tell us in black and white,” said Siphilangenkosi Dlamini.  

The fourth-year Governance and Political Transformation student at the University of the Free State (UFS) is the author of a book, titled Magic and Other Authentic Experiences. The book is a compilation of 13 short stories that follow the lives of a vast pool of characters as they experience chaos, love, and tragedy, among other things.

Some of the stories highlighted in the book

The chapter ‘The House on Marloth Street’ delineates the story of a young woman named Gracious, who is forced into prostitution to earn her keep by an elder in her life. The book also sheds light on the intricacies of young love through a story titled ‘The Suicide Note’. This story follows the lives of two characters named Menzi and Lulu, whose lives reach a devastating end because of secrets, deceit, and forbidden love. However, one of Dlamini’s favourite stories in the book is titled ‘Girl on the Bus’, which is based on a real-life occurrence. “It was one of those rare experiences where you meet someone and they are full of life,” he stated. 

The book is ultimately a manifestation of Dlamini’s love of literature. In fact, he argues that “these stories are a portrayal of different experiences of young people stepping into the world and trying to navigate life, love, and relationships”. This can be seen in the first story in the book, titled ‘Magic on Campus’, which is an account of Dlamini trying to pursue a young woman he met on campus, and highlighting how she made him feel. 

Making strides through literature

Dlamini’s authentic storytelling led to three of his stories being selected as part of the curriculum for the English Academic Literature module, which is included in most faculties at the UFS. As many of the students at the UFS are exposed to this work, he states that, “I would love this book to symbolise the importance of telling African stories”. Although Dlamini is making strides with this book, he is still working on expanding the book’s reach. “I’m emailing bookstores every day, trying to get the book into bookstores,” he said.

Future endeavours for the young author

As someone who strongly believes in the preservation of African literature and the portrayal of African love stories in their most authentic context, Dlamini is currently working on his next project. The project would count as his first novel and is a sequel to the stories from Magic and Other Authentic Experiences. In this novel, Dlamini explores a world in which the various characters are placed in a similar setting, and the experiences they would have if their lives were to intersect. 

The book is currently available for purchasing at R100 per copy. Those interested in purchasing a copy may contact Siphilangenkosi Dlamini on +27 84 374 0032 or 2018245304@ufs4life.ac.za.

Magic and Other Authentic Experiences book cover

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept